Linatilsan

Enalapril, the active ingredient in Linatilsan, is an ACE inhibitor presented as an oral tablet for oral use. It is prescribed to manage hypertension and several forms of heart failure, reducing cardiovascular strain in adult patients. By inhibiting the conversion of angiotensin I to angiotensin II, the drug promotes vasodilation and lowers blood pressure.

GNH USA supplies Linatilsan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export.

Enalapril is used in cardiovascular conditions that involve the renin‑angiotensin system.

Hypertension: lowers blood pressure and reduces the risk of stroke and heart attack. Heart failure: improves symptoms and decreases mortality in patients with reduced ejection fraction. Asymptomatic left ventricular dysfunction: delays progression to symptomatic heart failure. Post‑myocardial infarction: reduces the likelihood of subsequent cardiovascular events.

Enalapril may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Cough: persistent dry cough. - Dizziness: light‑headedness, especially after standing. - Headache: mild to moderate headache. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or throat. - Hyperkalemia: elevated blood potassium levels. - Neutropenia: reduced white blood cell count. - Hepatic dysfunction: abnormal liver enzymes or hepatitis.

When prescribing Enalapril, clinicians should consider several safety precautions to minimize risks. - Blood pressure monitoring: check for hypotension after initiation or dose changes. - Renal function assessment: evaluate serum creatinine and eGFR before and during therapy. - Electrolyte surveillance: monitor potassium levels to detect hyperkalemia. - Pregnancy and lactation: use only if clearly needed and after consulting a specialist. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Enalapril can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): can reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: ACE inhibition may raise lithium levels, requiring dose adjustment. - Diuretics (loop or thiazide): may enhance hypotensive effect; monitor blood pressure.